According to the head of the Gamalei microbiological center, a small amount of the drug that can be made will go into civilian circulation by mid-August
The vaccine from COVID-19 will undergo clinical trials and will receive appropriate permission for use in medical institutions by mid-August. This was announced by the Director of the National Research Center for Epidemiology and Microbiology. Gamalei (SRCEM) Alexander Gunzburg.
The center expects that the vaccine registration process will last until August 2–4, after which the procedure for obtaining a separate civil circulation permit at the Federal Service for Health and Social Development will take some time. “Well, somewhere around August 14–15, respectively, I hope that a small amount of the vaccine that can be developed will go into civilian circulation,” he said.